title: Proteomics to study Candida albicans biology and pathogenicity.
abstract: Candida albicans is an opportunistic pathogenic fungus capable of causing infections in an expanding population of immunosuppressed patients. The implementation of proteomics in the post-genomic era of this organism can provide vital information about its biological complexity and pathogenic traits. C. albicans proteomic analyses to date have focused on the understanding of the cell wall, virulence, dimorphism, antifungal drug effects and resistance, and serological response, among others. This exciting and rapid growing discipline should become an indispensable tool in C. albicans research, particularly to address problems that cannot be solved by genomic studies. Furthermore, in the near future it is expected that results from proteomic experiments will lead to novel techniques for the management of candidiasis.
authors.affiliation: Department of Biology, The University of Texas at San Antonio, Texas 78249, USA.
authors.forename: Derek P
authors.initials: DP
authors.lastname: Thomas
authors.forename: Aida
authors.initials: A
authors.lastname: Pitarch
authors.forename: Lucia
authors.initials: L
authors.lastname: Monteoliva
authors.forename: Concha
authors.initials: C
authors.lastname: Gil
authors.forename: Jose L
authors.initials: JL
authors.lastname: Lopez-Ribot
mesh_terms: D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology; D002176:Candida albicans / Q000187:drug effects / Q000378:metabolism* / Q000472:pathogenicity; D002177:Candidiasis / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control; D002473:Cell Wall / Q000737:chemistry; D025141:Drug Resistance, Fungal; D015180:Electrophoresis, Gel, Two-Dimensional; D005656:Fungal Proteins / Q000032:analysis* / Q000276:immunology; D006801:Humans; D040901:Proteomics / Q000379:methods*
chemical_list: D000935:Antifungal Agents; D005656:Fungal Proteins